MedPath

Trial of Chinese Prescription on Ulcerative Colitis

Not Applicable
Completed
Conditions
Ulcerative Colitis
Interventions
Drug: bascial prescription plus or minus herbs depend on symptoms
Registration Number
NCT00963287
Lead Sponsor
Shanghai University of Traditional Chinese Medicine
Brief Summary

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription on Ulcerative Colitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Clinical diagnosis of ulcerative colitis
  • Male of female patients between 18-65 years old
  • Written informed consent
Exclusion Criteria
  • Combine with malignant pathology on epithelial dysplasia of mucosa
  • Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
  • Pregnancy or breast feeding women, or unwilling to have contraception.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
bascial prescriptionbascial prescription plus or minus herbs depend on symptomsDecoction ,two times a day,one bag of decoction one time
low does of bascial decoctionbascial prescription plus or minus herbs depend on symptomsDecoction ,two times a day, one bag decoction of one time
Primary Outcome Measures
NameTimeMethod
Histopathological examination,enteroscopy,blood test,symptoms ,pulse tracings,tongue demonstration8 weeks
Secondary Outcome Measures
NameTimeMethod
Indicates of liver and renal function8 weeks

Trial Locations

Locations (1)

Longhua hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath